unknown
Stage
About
Biointaxis is a biotech academic spin-off developing gene therapy treatments for rare genetic diseases, specifically focusing on Friedreich's ataxia, and aims to license its products to pharmaceutical partners.
Explore Biointaxis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.